Clinical Trial Update: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov record reports a completed Phase 1 trial evaluating a dendritic cell-based idiotype vaccination in Stage I multiple myeloma and plasmacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasmacytoma

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Multiple Myeloma, Plasmocytoma | Phase 1 | Status: COMPLETED